NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/29/2025
Back to search
Official data from USPTO
IRPALIV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/30/2025
Trademark type
Word
Nice classes
5
Filing date
11/12/2023
Registration date
04/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
04/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Shanghai, CN
Examiner
DESAI,BRIN ANDERSON
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Abbisko Therapeutics Co., Ltd.
Representatives
Yue (Robert) Xu APEX ATTORNEYS AT LAW, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposesmedicinal preparations for the treatment of cancer; Coated capsule anti-tumor medicines for prevention and treatment of human cancer; Pharmaceutical preparations for suppressing tumors; Chemico-pharmaceutical preparationschemical preparations for pharmaceutical or medical purposesfor use in the treatment of cancer; Drugs for medical purposespharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposesbiological preparations for the treatment of cancer; Chemical preparations for medical and pharmaceutical use for treating oncological diseasesliver cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
OTHE
CASE RETURNED TO EXAMINATION
02/20/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/20/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
02/10/2025
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
02/10/2025
APET
ASSIGNED TO PETITION STAFF
02/10/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
12/28/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/15/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2024
PUBO
PUBLISHED FOR OPPOSITION
08/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/17/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2024
GNRT
NON-FINAL ACTION E-MAILED
06/27/2024
CNRT
NON-FINAL ACTION WRITTEN
06/27/2024
DOCK
ASSIGNED TO EXAMINER
06/19/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2023
NWAP
NEW APPLICATION ENTERED
11/15/2023
Continuous trademark protection
Get notified about every new filing that threatens IRPALIV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.